146 related articles for article (PubMed ID: 35815088)
1. The capacity of HIV in the blood and the cerebrospinal fluid depending on antiretroviral drugs.
Boiko YI; Moskaliuk VD; Randuk YO; Balaniuk IV; Rudan IV; Kolotylo TR; Melenko SR
J Med Life; 2022 May; 15(5):620-624. PubMed ID: 35815088
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.
Cinque P; Bestetti A; Morelli P; Presi S
J Neurovirol; 2000 May; 6 Suppl 1():S95-S102. PubMed ID: 10871772
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.
Ellis RJ; Childers ME; Zimmerman JD; Frost SD; Deutsch R; McCutchan JA;
J Infect Dis; 2003 Jun; 187(11):1818-21. PubMed ID: 12751041
[TBL] [Abstract][Full Text] [Related]
5. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
[TBL] [Abstract][Full Text] [Related]
6. HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid.
Eggers CC; van Lunzen J; Buhk T; Stellbrink HJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):259-64. PubMed ID: 10077174
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study.
Gisslén M; Hagberg L; Fuchs D; Norkrans G; Svennerholm B
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):291-5. PubMed ID: 9525428
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir.
Kravcik S; Gallicano K; Roth V; Cassol S; Hawley-Foss N; Badley A; Cameron DW
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):371-5. PubMed ID: 10458617
[TBL] [Abstract][Full Text] [Related]
9. [Cerebrospinal fluid viral load in HIV-1 positive hemophilic patients treated with HAART].
Corti ME; Villafañe MF; Baré P; Alves Rosa F; Cermelj M; Candela M; Pérez Bianco R; Tezanos Pinto M
Medicina (B Aires); 2001; 61(6):821-4. PubMed ID: 11808421
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.
Antinori A; Giancola ML; Grisetti S; Soldani F; Alba L; Liuzzi G; Amendola A; Capobianchi M; Tozzi V; Perno CF
AIDS; 2002 Sep; 16(14):1867-76. PubMed ID: 12351946
[TBL] [Abstract][Full Text] [Related]
11. Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.
Yilmaz A; Verhofstede C; D'Avolio A; Watson V; Hagberg L; Fuchs D; Svennerholm B; Gisslén M
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):590-6. PubMed ID: 20847699
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR.
de Oliveira MF; Gianella S; Letendre S; Scheffler K; Kosakovsky Pond SL; Smith DM; Strain M; Ellis RJ
PLoS One; 2015; 10(10):e0139510. PubMed ID: 26431315
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.
García F; Alonso MM; Romeu J; Knobel H; Arrizabalaga J; Ferrer E; Dalmau D; Ruiz I; Vidal F; Frances A; Segura F; Gomez-Sirvent JL; Cruceta A; Clotet B; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
J Acquir Immune Defic Syndr; 2000 Sep; 25(1):26-35. PubMed ID: 11064501
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
[TBL] [Abstract][Full Text] [Related]
16. Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
Edén A; Nilsson S; Hagberg L; Fuchs D; Zetterberg H; Svennerholm B; Gisslén M
J Infect Dis; 2016 Dec; 214(12):1822-1825. PubMed ID: 27683820
[TBL] [Abstract][Full Text] [Related]
17. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.
Dravid AN; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Wadia RS
Medicine (Baltimore); 2018 Feb; 97(8):e9969. PubMed ID: 29465595
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.
Sinclair E; Ronquillo R; Lollo N; Deeks SG; Hunt P; Yiannoutsos CT; Spudich S; Price RW
J Acquir Immune Defic Syndr; 2008 Apr; 47(5):544-52. PubMed ID: 18362693
[TBL] [Abstract][Full Text] [Related]
19. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.
Gisslén M; Fuchs D; Svennerholm B; Hagberg L
J Acquir Immune Defic Syndr; 1999 Aug; 21(4):271-6. PubMed ID: 10428104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
